Endo's $600M DAVA Deal Provides Case Study In Pharma M&A
By Karlee Weinmann ( June 24, 2014, 4:13 PM EDT) -- Irish drugmaker Endo International PLC said Tuesday that it would expand its product pipeline by scooping up DAVA Pharmaceuticals Inc. in a deal worth up to $600 million that underscores several of the major forces behind this year's surge in pharma M&A....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.